Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men
C. Le(Johns Hopkins University), Judith S. Currier(University of California, Los Angeles), Ronald J. Bosch(Harvard University), Jonathan Z. Li(Brigham and Women's Hospital), James McIntyre(Perinatal HIV Research Unit), Rajesh T. Gandhi(Harvard University), Anne Coletti(Family Health International 360), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Sean S. Brummel(Harvard University), Karin L. Klingman(National Institutes of Health), Mary Glenn Fowler(Johns Hopkins University), Patricia M. Flynn(St. Jude Children's Research Hospital), Paula Britto(Cancer Research And Biostatistics), Risa M. Hoffman(University of California, Los Angeles)
Cited by 20
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k